PHAR - Pharming Group NV Qarzning balans kapitallashuviga nisbati

Pharming Group NV (PHAR) grafik logotipi

Pharming Group N.V. (PHAR) hayotlarni haqiqatda saqlab qolishga intiluvchi yetakchi biologlarning tajribasiga tayanadi. Biznes modeli bemorlarning eksklyuziv dori vositalariga to'liq bog'liqligiga asoslangan, daromadlilik esa hukumat nazorati bilan cheklangan va 0.49 darajasida turibdi. Kompaniya shuningdek, dori vositalarini ishlab chiqish jarayonida "yashil kimyo" va bioetika tamoyillarini joriy etadi. Ushbu PHAR narxlar grafigi immun terapiyasi ishlab chiqaruvchisining bozor dinamikasini aniq vizuallashtiradi.

PHAR (Pharming Corp) Qarzning balans qiymatiga nisbati tarixi 04.07.2022dan 27.10.2026gacha
Pharming Group NV asosiy tovari

Ushbu ko'rsatkich balans qiymatiga asoslangan holda kapitalga nisbatan qarzdorlik ulushini belgilaydi, bu esa bozor tebranishlarining ta'sirisiz haqiqiy moliyaviy leverajni baholash imkonini beradi. Barqaror joriy balans hisoboti leveraj koeffitsiyenti Pharming Group N.V. (PHAR) kompaniyasining global sotuvlarni kengaytirish jarayonida kredit risklarini minimallashtirgan holda, kamyob dorilar ishlab chiqarishni kengaytirishni o'z resurslari hisobidan moliyalashtirish qobiliyatini tasdiqlaydi.

Pharming Group N.V. kimlar bilan raqobatlashadi

Balans kapitallashuviga qarzlar ARGX (argenx SE)|biontech.de - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati ABIVAX (ABVX)|ADMA: Qarzning sof aktivlarga nisbati|PTGX (Protagonist Therapeutics Inc) - Qarzning balans kapitallashuviga nisbati|Immunovant Therapeutics (IMVT) - Qarzning balans qiymatiga nisbati|KNSA (Kiniksa Pharmaceuticals) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar grifols.com (GRFS)|Adaptive Biotechnologies Corporation (ADPT) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Celldex Therapeutics Inc (CLDX)|Balans kapitallashuviga qarzlar AUPH|BioCryst Corp - Sof aktivlarga qarzlar|VERA: Qarzning balans kapitallashuviga nisbati|DNTH: Qarzning balans qiymatiga nisbati|PHVS (Pharvaris) - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati AbCellera Bio|TRML (Tourmaline Corp) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar PGEN|Qarzning balans kapitallashuviga nisbati Nektar Therapeutics NKTR|Qarzning balans qiymatiga nisbati upstreambio.com (UPB)|ZBIO: Balans kapitallashuviga qarzlar|Immunome Inc - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Gossamer Corp|KALV - Qarzlarning balans kapitallashuviga nisbati|Balans kapitallashuviga qarzlar Septerna Inc SEPN|pieris.com (PVLA) - Qarzning sof aktivlarga nisbati|SVRA (Savara) - Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar RIGL|AnaptysBio Corp (ANAB) - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati ATXS (Astria Corp)|enGene Holdings Inc. - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati RAPT Therapeutics Inc. RAPT|Balans kapitallashuviga qarzlar JBIO (Aerovate)|ACRS: Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Kyverna|Tiziana Life Sciences, Ltd. (TLSA) - Qarzning balans qiymatiga nisbati|Cabaletta Bio, Inc. - Balans kapitallashuviga qarzlar|Qarzning sof aktivlarga nisbati ventyxbio.com (VTYX)|Theratechnologies (THTX) - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati Avalo Therapeutics, Inc. (AVTX)|ELDN (Eledon) - Balans kapitallashuviga qarzlar|Agenus, Inc - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati Climb Bio Inc (CLYM)|ZURA: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ATYR|Balans qiymatiga qarzlar Adagene Inc.|IMA (ImageneBio) - Qarzning balans qiymatiga nisbati|Balans kapitallashuviga qarzlar STTK|EQ - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati connectbiopharm.com CNTB|Qarzning balans qiymatiga nisbati Immunic|Atara Biotherapeutics, Inc. - Qarzning sof aktivlarga nisbati|InflaRx GmbH (IFRX) - Qarzning balans kapitallashuviga nisbati|X4 Pharmaceuticals, Inc (XFOR) - Qarzning balans qiymatiga nisbati|adicetbio.com - Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar Celularity|Qarzning balans qiymatiga nisbati INmune Bio|Qarzning balans kapitallashuviga nisbati Barinthus Biotherapeutics PLC (BRNS)|KZR (Kezar Life Sciences, Inc) - Qarzning balans qiymatiga nisbati|Sof aktivlarga qarzlar SABS (SAB Biotherapeutics Inc)|Akari Therapeutics (AKTX) - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati Enlivex Therapeutics Ltd ENLV|Balans kapitallashuviga qarzlar Q32 Bio Corp (QTTB)|GOVX - Qarzning sof aktivlarga nisbati|EDSA: Balans kapitallashuviga qarzlar|IBIO (iBio Corporation) - Balans kapitallashuviga qarzlar|CARM - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati XTLB|BOLT - Qarzning balans kapitallashuviga nisbati|Qarzlarning balans kapitallashuviga nisbati hcwbiologics.com (HCWB)|Balans kapitallashuviga qarzlar Aptevo Therapeutics Inc.|Qarzning sof aktivlarga nisbati AIM ImmunoTech, Inc. AIM|Aditxt Corp - Balans kapitallashuviga qarzlar|GRI: Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati XORTX Therapeutics XRTX|HIND (Vyome Holdings Inc.) - Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati REVB|Qarzning balans qiymatiga nisbati Indaptus Corp|Balans kapitallashuviga qarzlar SCNI|Balans kapitallashuviga qarzlar calcimedica.com CALI|Qarzning balans qiymatiga nisbati Affimed N.V.|Qarzning sof aktivlarga nisbati Allakos Inc ALLK|Balans kapitallashuviga qarzlar HOOK (HOOKIPA)|IGMS: Sof aktivlarga qarzlar|ITOS (iTeos Therapeutics) - Qarzning balans kapitallashuviga nisbati|OCEA (oceanbiomedical.com) - Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati TCBP|Qarzning balans qiymatiga nisbati Third Harmonic Bio Inc. (THRD)